Microbial polysaccharides: An emerging family of natural biomaterials for cancer therapy and diagnostics

Microbial polysaccharides (MPs) offer immense diversity in structural and functional properties. They are extensively used in advance biomedical science owing to their superior biodegradability, hemocompatibility, and capability to imitate the natural extracellular matrix microenvironment. Ease in tailoring, inherent bio-activity, distinct mucoadhesiveness, ability to absorb hydrophobic drugs, and plentiful availability of MPs make them prolific green biomaterials to overcome the significant constraints of cancer chemotherapeutics. Many studies have demonstrated their application to obstruct tumor development and extend survival through immune activation, apoptosis induction, and cell cycle arrest by MPs. Synoptic investigations of MPs are compulsory to decode applied basics in recent inclinations towards cancer regimens. The current review focuses on the anticancer properties of commercially available and newly explored MPs, and outlines their direct and indirect mode of action. The review also highlights cutting-edge MPs-based drug delivery systems to augment the specificity and efficiency of available chemotherapeutics, as well as their emerging role in theranostics.

Surface Pressure Analysis of Poly(ethylene oxide)-Modified Fusogenic Liposomes Incorporated into a Phospholipid Monolayer

Fusogenic liposomes have a wide-range of applications as DDS and gene/protein delivery into living cells. A variety of surface modifications of drug carriers, to enable fusion with cells, have been proposed, however, the mechanism of fusion has still not been determined. To further improve the efficiency of drug carriers, a simple and easily examinable model of a living cell surface is needed. In this study, the time-course of a fusion phenomena was made by measuring the surface pressure increase of a phospholipid monolayer spread at the air/water interface due to the fusion of liposomes carrying PEO-lipid (dialkyl-terminated polyethylene oxide) reconstituted on their outer surface. The kinetics of the surface pressure change appeared to be bimodal, indicating the coexistence of different fusion pathways. It was found that the presence of the PEO-lipid on the liposome surface led to a faster lipid transfer compared to non-modified DMPC liposomes. This indicated that the reconstitution of PEO-lipid provided an alternative transfer pathway to that for non-fusogenic liposomes that show only a slow lipid transfer to phospholipid monolayers. The relation between the rate of fusion and the surface pressure of the host membrane is discussed.

Green synthesis of folic acid-conjugated gold nanoparticles with pectin as reducing/stabilizing agent for cancer theranostics

The one pot aqueous green synthesis of gold nanoparticles (GNPs) decorated with folic acid and loaded with doxorubicin suitable for anti-cancer drug delivery was potentially promising as a new therapeutic system for cancer treatment.

Succinylated polysaccharide-based thermosensitive polyelectrostatic complex for protein drug delivery

The objective of this study was to develop a thermosensitive polyelectrostatic complex, based on polysaccharides, as carriers for long-term protein delivery. We developed a thermosensitive polyelectrostatic complex formed through combined electrostatic and hydrophobic interactions. The copolymer (succinylated pullulan -poly(l-lactide)) showed thermosensitivity in aqueous solution and complexed with protein (lysozyme) via electrostatic attractions and hydrophobic interactions at physiological temperature which formed a thermosensitive polyelectrostatic complex. The particle size of the thermosensitive polyelectrostatic complex was decreased from ~520 nm at 4°C to ~190 nm at 37.5°C. These thermosensitive polyelectrostatic complexes were stable in serum and salt conditions, and maintained the bioactivity of encapsulated protein for 36 days. The thermosensitive polyelectrostatic complex had prolonged in vivo stability that was greater than the polyelectrostatic complex. Based on stability and bioactivity tests for the lysozyme-loaded thermosensitive polyelectrostatic complexes, the potential of the long-term protein delivery carrier in physiological conditions was confirmed.

Folate-decorated maleilated pullulan-doxorubicin conjugate for active tumor-targeted drug delivery

A novel folate-decorated maleilated pullulan-doxorubicin conjugate (abbreviated as FA-MP-DOX) for active tumor targeting was set up. The structure of this conjugate was confirmed by (1)H NMR analysis. Furthermore, the conjugation efficiency, drug release property and stability of the conjugate were determined. The cellular uptake and cytotoxicity were assessed by using ovarian carcinoma A2780 cells as in vitro cell model. In vitro DOX release from FA-MP-DOX conjugate occurred at a faster rate at acidic pH compared to neutral pH (7.4). After 30 h of incubation at pH 2.5, 5.0 and 7.4 the released free DOX was about 68.71%, 50.08% and 26%, respectively. Based on the IC(50) values, the conjugate was found more effective with ovarian carcinoma A2780 cells than the parent drug after 48 h culture. These results suggested that FA-MP-DOX conjugate could be a promising doxorubicin carrier for its targeted and intracellular delivery.

Hybrid nanomaterials for biomedical applications

Hybrid nanomaterials, composed of both inorganic and organic components, have recently been examined as promising platforms for imaging and therapeutic applications. This unique class of nanomaterials can not only retain beneficial features of both the inorganic and organic components, but also provides the ability to systematically tune the properties of the hybrid material through the combination of functional components. This feature article will summarize recent advances in the design and synthesis of hybrid nanomaterials and their applications in biological and biomedical areas. The hybrid nanomaterials to be discussed fall into two main categories, silica based materials and nanoscale metal-organic frameworks. Their applications as imaging contrast agents and nanotherapeutics will be highlighted.

New Polysaccharide-based Microparticles Crosslinked with Siloxane: Interactions with Biologically Active Substances

The interaction of microparticles of carboxymethyl pullulan crosslinked with siloxane (provided by a new crosslinking agent: 3-(glycid oxypropyl) trimethoxysilane) with biologically active molecules, such as enzymes (lysozyme) and drugs (propranolol, quinidine) was studied. The anionic amphiphilic supports retained through electrostatic and/or hydrophobic forces, variable amounts of the substances as a function of their structure, such as crosslinking degree and amount of uncrosslinked alkylsilane chains. The absorption of lysozyme on the supports followed the Langmuir isotherm, which allowed the calculation of constants k1 and k2. Both retention and in vitro release behavior of these support potential applications in controlled drug release as well as immobilization and purification of enzymes.